Interleukin-8(IL-8);
Ovarian cancer (OVCA);
Malignant behaviors;
PI3K/Akt and Raf/MEK/ERK signaling;
HUMAN BLADDER-CANCER;
FACTOR-KAPPA-B;
EXPRESSION REGULATES TUMORIGENICITY;
PROSTATE-CANCER;
CARCINOMA CELLS;
FACTOR RECEPTOR;
TUMOR-GROWTH;
ENDOTHELIAL-CELLS;
HUMAN-MELANOMA;
UP-REGULATION;
D O I:
10.1016/j.cyto.2012.04.013
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
It has been shown that IL-8 is elevated in ovarian cyst fluid, ascites, serum, and tumor tissue from ovarian cancer (OVCA) patients, and increased IL-8 expression correlates with poor prognosis and survival. However, the exact role that IL-8 plays in this malignancy or whether IL-8 can regulate malignant behavior has not been established. Here we demonstrate that overexpression of IL-8 in non-IL-8-expressing A2780 cells (by transfecting with plasmid encoding for sense IL-8) increases anchorage-independent growth, proliferation, angiogenic potential, adhesion and invasion while depletion of endogenous IL-8 expression in IL-8-overexpressing SKOV-3 cells (by transfecting with plasmid encoding for antisense IL-8) decreases the above effects. Further investigation indicates that IL-8-stimulated cell proliferation correlates with alteration of cell cycle distribution by increasing levels of cell cycle-regulated Cyclin D1 and Cyclin B1 proteins as well as activation of PI3K/Akt and Raf/MEK/ERK, whereas IL-8-enhanced OVCA cell invasive correlates with increased MMP-2 and MMP-9 activity and expression. Our data suggest that IL-8 secreted by OVCA cells promotes malignant behavior of these cells via inducing intracellular molecular signaling. Therefore, modulation of IL-8 expression or its related signaling pathway may be a promising strategy for controlling the progression and metastasis of OVCA. (C) 2012 Elsevier Ltd. All rights reserved.
机构:
Univ Nottingham, Queens Med Ctr, Div Therapeut, Nottingham NG7 2UH, EnglandUniv Nottingham, Queens Med Ctr, Div Therapeut, Nottingham NG7 2UH, England
Glynn, PC
Henney, E
论文数: 0引用数: 0
h-index: 0
机构:
Univ Nottingham, Queens Med Ctr, Div Therapeut, Nottingham NG7 2UH, EnglandUniv Nottingham, Queens Med Ctr, Div Therapeut, Nottingham NG7 2UH, England
Henney, E
Hall, IP
论文数: 0引用数: 0
h-index: 0
机构:
Univ Nottingham, Queens Med Ctr, Div Therapeut, Nottingham NG7 2UH, EnglandUniv Nottingham, Queens Med Ctr, Div Therapeut, Nottingham NG7 2UH, England
机构:
Univ Nottingham, Queens Med Ctr, Div Therapeut, Nottingham NG7 2UH, EnglandUniv Nottingham, Queens Med Ctr, Div Therapeut, Nottingham NG7 2UH, England
Glynn, PC
Henney, E
论文数: 0引用数: 0
h-index: 0
机构:
Univ Nottingham, Queens Med Ctr, Div Therapeut, Nottingham NG7 2UH, EnglandUniv Nottingham, Queens Med Ctr, Div Therapeut, Nottingham NG7 2UH, England
Henney, E
Hall, IP
论文数: 0引用数: 0
h-index: 0
机构:
Univ Nottingham, Queens Med Ctr, Div Therapeut, Nottingham NG7 2UH, EnglandUniv Nottingham, Queens Med Ctr, Div Therapeut, Nottingham NG7 2UH, England